Sarepta Therapeutics Inc [NASDAQ: SRPT] slipped around -15.24 points on N/A, while shares priced at $20.94 at the close of the session, down -42.12%.
Compared to the average trading volume of 3.85M shares, SRPT reached a trading volume of 43108503 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sarepta Therapeutics Inc [SRPT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SRPT shares is $69.68 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SRPT stock is a recommendation set at 1.86. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Sarepta Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on June 16, 2025. The new note on the price target was released on June 16, 2025, representing the official price target for Sarepta Therapeutics Inc stock. Previously, the target price had yet another raise to $10, while H.C. Wainwright analysts kept a Sell rating on SRPT stock.
The Average True Range (ATR) for Sarepta Therapeutics Inc is set at 3.77, with the Price to Sales ratio for SRPT stock in the period of the last 12 months amounting to 0.92. The Price to Book ratio for the last quarter was 1.80, with the Price to Cash per share for the same quarter was set at 5.32.
How has SRPT stock performed recently?
Sarepta Therapeutics Inc [SRPT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -47.27. With this latest performance, SRPT shares dropped by -40.63% in over the last four-week period, additionally sinking by -83.30% over the last 6 months – not to mention a drop of -82.55% in the past year of trading.
Sarepta Therapeutics Inc [SRPT]: Deeper insight into the fundamentals
Sarepta Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.46 and a Current Ratio set at 4.02.
Earnings analysis for Sarepta Therapeutics Inc [SRPT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SRPT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sarepta Therapeutics Inc go to 38.48%.
Insider trade positions for Sarepta Therapeutics Inc [SRPT]
The top three institutional holders of SRPT stocks are: BLACKROCK INC. with ownership of 10.32 million shares, which is approximately 10.9117%. VANGUARD GROUP INC, holding 9.04 million shares of the stock with an approximate value of $$1.43 billion in SRPT stocks shares; and VANGUARD GROUP INC, currently with $$682.69 million in SRPT stock with ownership which is approximately 4.5666%.
